Industry News
Early trial of new drug shows promise for patients with triple-negative breast cancer
Dec 15, 2014
In patients with metastatic triple-negative breast cancer--a disease with no approved targeted therapies--infusion of pembrolizumab produced durable responses in almost one out of five patients... Read More
Study shows superior activity for nab-paclitaxel vs paclitxel in early breast cancer
Dec 15, 2014
The German Breast Group (GBG) said nab-paclitaxel (ABRAXANE®) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional solvent-based... Read More
Immune function marker does not predict benefit of trastuzumab in HER-2+ breast cancer
Dec 15, 2014
A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also linked to improved prognosis in patients treated with... Read More
Hormone-unrelated breast cancer death rate lowered by reducing dietary fat
Dec 15, 2014
Researchers found that death rates in early-stage breast cancer patients with hormone-unrelated breast cancer fell significantly, following a reduction in dietary fat intake. Read More
Genotyping errors plague CYP2D6 testing for tamoxifen therapy
Dec 15, 2014
Clinical recommendations discouraging the use of CYP2D6 gene testing to guide tamoxifen therapy in breast cancer patients are based on studies with flawed methodology and should be reconsidered... Read More
More than three years after pulsed-KTP laser treatment, 96 percent of patients with early vocal-cord tumors are cancer-free
Dec 14, 2014
The first long-term study of a pioneering endoscopic laser treatment for early vocal-cord cancer, developed at Massachusetts General Hospital (MGH) and previously shown to provide optimal voice... Read More
Women with dense breasts will have to look beyond ultrasound for useful supplemental breast cancer screening
Dec 14, 2014
Supplemental ultrasound screening for all U.S. women with dense breasts would substantially increase healthcare costs with little improvement in overall health, according to senior author Anna... Read More
Increased use of hypofractionated whole-breast irradiation benefits patients with early-stage breast cancer
Dec 14, 2014
The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17. Read More
Discovery of possible genetic link in pediatric leukemia treatment-related cognitive issues
Dec 13, 2014
Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning and other cognitive functions seen in... Read More
In patients with BRCA1/2 mutations, common chemotherapy not found to be heart toxic
Dec 13, 2014
Use of anthracycline-based chemotherapy, a common treatment for breast cancer, has negligible cardiac toxicity in women whose tumors have BRCA1/2 mutations -- despite preclinical evidence that such... Read More
Previous Page Next Page